Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
11.1%
% of XLV's 63 holdings also in XDNA
30.4%
% of XDNA's 23 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 5.6% | 3.8% | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.7% | 9.5% | 3.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.6% | 1.6% | 1.6% |
|
VERTEX PHARMACEUTICALS INC | 2.3% | 1.5% | 1.5% |
|
REGENERON PHARMACEUTICALS | 2.1% | 1.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to XDNA
|
ELI LILLY & CO | 12.5% |
|
UNITEDHEALTH GROUP INC | 9.5% |
|
JOHNSON & JOHNSON | 6.8% |
|
MERCK & CO. INC. | 5.8% |
|
AMGEN INC | 3.3% |
|
ABBOTT LABORATORIES | 3.3% |
|
PFIZER INC | 3.1% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
DANAHER CORP | 2.9% |
|
ELEVANCE HEALTH INC | 2.1% |
XLV Underweight Relative to XDNA
|
CRISPR THERAPEUTICS AG | -15.1% |
|
BEAM THERAPEUTICS, INC. | -13.7% |
|
INTELLIA THERAPEUTICS, INC. | -8.7% |
|
PRIME MEDICINE, INC. | -5.9% |
|
THERMO FISHER SCIENTIFIC INC | -5.8% |
|
EDITAS MEDICINE, INC. | -5.7% |
|
CARIBOU BIOSCIENCES, INC. | -4.7% |
|
VERVE THERAPEUTICS, INC. | -4.5% |
|
POSEIDA THERAPEUTICS, INC. | -4.1% |
|
ALLOGENE THERAPEUTICS, INC. | -3.4% |